Enhanced Late Na+ Currents in Atrial Fibrillation. New Drug Target or Just an Epiphenomenon?

Journal of the American College of Cardiology

Volumn 55, Issue 21, 2010, Pages 2343-2345

  Schotten, Ulrich ^a   Verheule, Sander ^a   Kerfant, Benoit Gilles ^a   Greiser, Maura ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

antiarrhythmia agents; atrial fibrillation; diastolic function; sodium channels

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); RANOLAZINE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION;

ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; CONCENTRATION RESPONSE; EDITORIAL; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; IC 50; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SINUS RHYTHM; SODIUM CURRENT; UNSTABLE ANGINA PECTORIS;

ACETANILIDES; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; FEMALE; HEART ATRIA; HUMANS; MALE; MYOCYTES, CARDIAC; PIPERAZINES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SODIUM CHANNELS;

EID: 77952201215     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.046     Document Type: Editorial

References (16)

1. + currents in atrial fibrillation: effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 55 (2010) 2330-2342
2. Schotten U., Greiser M., Benke D., et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res 53 (2002) 192-201
3. El-Armouche A., Boknik P., Eschenhagen T., et al. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation 114 (2006) 670-680
4. Miyata A.Z.D., Hall S., and Rubart M. Kb-R7943 prevents acute, atrial fibrillation-induced shortening of atrial refractoriness in anesthetized dogs. Circulation 106 (2002) 1410-1419
5. Workman A.J., Kane K.A., and Rankin A.C. Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res 59 (2003) 593-602
6. Jayachandran J.V., Zipes D.P., Weksler J., and Olgin J.E. Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling. Circulation 101 (2000) 1861-1866
7. Bosch R.F., Zeng X., Grammer J.B., et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44 (1999) 121-131
8. Gaspo R., Bosch R.F., Bou-Abboud E., et al. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. Circ Res 81 (1997) 1045-1052
9. Wagner S., Dybkova N., Rasenack E.C., et al. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest 116 (2006) 3127-3138
10. Akar J.G., Everett T.H., Ho R., et al. Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation. Circulation 107 (2003) 1810-1815
11. Chaitman B.R., Skettino S.L., Parker J.O., et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 43 (2004) 1375-1382
12. Scirica B.M., Morrow D.A., Hod H., et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116 (2007) 1647-1652
13. McCormack J.G., Barr R.L., Wolff A.A., and Lopaschuk G.D. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93 (1996) 135-142
14. Schram G., Zhang L., Derakhchan K., Ehrlich J.R., Belardinelli L., and Nattel S. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects. Br J Pharmacol 142 (2004) 1300-1308
15. Burashnikov A., Di Diego J.M., Zygmunt A.C., Belardinelli L., and Antzelevitch C. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116 (2007) 1449-1457
16. Sicouri S., Glass A., Belardinelli L., and Antzelevitch C. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. Heart Rhythm 5 (2008) 1019-1026